Tamsulosin Hydrochloride
Product Images NDC 43353-663

This is a description of a medication called Tamsulosin HCI which consists of 0.4mg capsules that come in a package of 30 capsules. The medication should be stored at room temperature and kept away from children. The manufacturer of the medication is Rottendorf Pharma GmbH and it has been repackaged by Aphena Pharma. The NDC number for the medication is 43353-0663-30.*

Mean change over the duration of treatment (in weeks) for different treatments including 1000/8mg, AN/4mg, and placebo. The duration of treatment ranges from 2 weeks to 6 weeks. The data is based on a sample size of 755, 717, 693, 665, 637, 619, and 616, respectively, up to LOCF (Last Observation Carried Forward).*

This appears to be a table showing data related to treatments (possibly medical) with duration of the treatment in weeks. The specific treatment isn't specified as the data only shows values for the duration of the treatment. The table shows the duration of the treatment and the number of occurrences in the sample size for each duration. However, there are non-English characters mixed with the text making it difficult to interpret the values accurately.*

This text seems to be describing a chart or table that shows data related to a treatment, where a medication and a placebo were likely compared in terms of their effectiveness. The chart contains a header labeled "Treatment" and then lists some numbers that may represent dosages or concentrations. The "@" symbol appears before some additional data, including numbers and letters that are unclear. The chart also appears to contain numbers organized into rows and columns, possibly indicating measurements taken at different points in time or under different conditions. However, without more context or additional information, it is difficult to provide a more accurate description or interpretation of this text.*

This text is displaying data related to the treatment duration of a medication. It includes the number of patients included in the study (n), the duration of treatment in weeks, and some graphs showing the dosage and response rate. No additional information is available.*